RESUMO
Expanding uterine masses can be the cause of pregnancy loss and add technical difficulties to uterus evacuation due to the intense anatomical distortion of the endocervical canal and uterine cavity. The literature is scarce in the peculiarities of the management of missed abortions in uterus with important distorted anatomies. We report a case of a primigravida patient who presented a rapid and expressive increase of abdominal volume due to a giant uterine mass, evolving to miscarriage. Ultrasound can be a useful tool, allowing visualization of the endocervical path and uterine cavity, helping to perform uterine evacuation in the presence of anatomical distortion without compromising the reproductive future. To the best of our knowledge, no such case has been previously reported.
Assuntos
Aborto Espontâneo , Neoplasias Uterinas , Humanos , Feminino , Neoplasias Uterinas/diagnóstico por imagem , Neoplasias Uterinas/cirurgia , Neoplasias Uterinas/patologia , Gravidez , Adulto , Ultrassonografia , Complicações Neoplásicas na Gravidez/diagnóstico por imagem , Complicações Neoplásicas na Gravidez/patologia , Complicações Neoplásicas na Gravidez/cirurgia , Leiomioma/diagnóstico por imagem , Leiomioma/cirurgia , Leiomioma/patologiaRESUMO
Expanding uterine masses can be the cause of pregnancy loss and add technical difficulties to uterus evacuation due to the intense anatomical distortion of the endocervical canal and uterine cavity. The literature is scarce in the peculiarities of the management of missed abortions in uterus with important distorted anatomies. We report a case of a primigravida patient who presented a rapid and expressive increase of abdominal volume due to a giant uterine mass, evolving to miscarriage. Ultrasound can be a useful tool, allowing visualization of the endocervical path and uterine cavity, helping to perform uterine evacuation in the presence of anatomical distortion without compromising the reproductive future. To the best of our knowledge, no such case has been previously reported.
RESUMO
OBJECTIVE: To evaluate the maternal-fetal outcomes of CAB-induced pregnancies in patients with prolactinoma in a large cohort. METHODS: The prevalence of tumor growth, miscarriage, preterm, low birth weight, congenital malformations and impairment in neuropsychological development in children among women treated with CAB were assessed in a Brazilian multicentre retrospective observational study, RESULTS: We included 194 women with a mean age of 31 (17-45) years, 43.6% presenting microadenomas and 56.4% macroadenomas, at prolactinoma diagnosis. In 233 pregnancies, CAB was withdrawn in 89%, after pregnancy confirmation. Symptoms related to tumor growth occurred in 25 cases, more frequently in macroadenomas. The overall miscarriage rate was 11%, although higher in the subgroup of patients with CAB maintainance after pregnancy confirmation (38% vs. 7.5%). Amongst the live-birth deliveries, preterm occurred in 12%, low birth weight in 6% and congenital malformations in 4.3%. Neuropsychological development impairment was reported in 7% of cases. CONCLUSIONS: Our findings confirm previous results of safety in maternal and fetal outcomes in CAB-induced pregnancies; nevertheless, CAB maintenance after pregnancy confirmation was associated with higher miscarriage rate; result that must be further confirmed.
Assuntos
Cabergolina/uso terapêutico , Agonistas de Dopamina/uso terapêutico , Prolactinoma/patologia , Aborto Espontâneo/patologia , Adolescente , Adulto , Idoso , Feminino , Humanos , Hiperprolactinemia/patologia , Pessoa de Meia-Idade , Gravidez , Complicações Neoplásicas na Gravidez , Estudos Retrospectivos , Adulto JovemRESUMO
INTRODUCTION: The diagnosis of renal function impairment and deterioration in congenital urinary tract obstruction (UTO) continues to be extremely challenging. The use of new renal biomarkers in this setting may favor early renal injury detection, allowing for a reliable choice of optimal therapeutic options and the prevention or minimization of definitive renal damage. OBJECTIVE: The aim of the study was to investigate a selection of promising biomarkers of renal injury with the intention of evaluating and comparing their profile with clinically based decisions for surgical intervention of infants with congenital obstructive uropathies. STUDY DESIGN: The first-year profile of renal biomarkers, serum creatinine (sCr), serum and urine cystatin C (CyC), neutrophil gelatinase-associated lipocalin (NGAL), kidney injury molecule-1 (KIM-1), transforming growth factor beta-1 (TGF-ß1), retinol-binding protein (RBP), and microalbuminuria (µALB), was analyzed in a cohort of 37 infants with congenital UTO, divided into three subgroups, 14 cases with grade III unilateral hydro(uretero)nephrosis, 13 cases with grade III bilateral hydro(uretero)nephrosis, and 10 cases with low urinary tract obstruction (LUTO), compared with 24 healthy infants matched by gestational age and birth weight. Serum and urine samples were stored at -70 °C and thereafter analyzed by quantitative enzymatic immunoassay. RESULTS: Compared with the control group (Figure), all renal biomarker values were significantly increased in patients (P ≤ 0.02). In the unilateral hydronephrosis and LUTO group, RBP (P ≤ 0.043), NGAL (P ≤ 0.043), KIM-1 (P ≤ 0.03), and TGF-ß1 (P ≤ 0.034) values dropped significantly after surgery. Neutrophil gelatinase-associated lipocalin alone and in combination with urine and serum CyC demonstrated the best performance in determining the need for surgery (area under the curve, 0.801 and 0.881, respectively). Biomarker profile analysis was suggestive of surgical intervention in 55.4% (7/13) of non-operated cases, and most of the biomarker values were above the cutoff levels within at least 3 months before the clinically based surgical decision in 58% (14/24) of all operated patients. DISCUSSION: To the best of the authors' knowledge, this is the first study to present the clinical use of selected group of serum and urinary biomarkers in the setting of UTO to distinguish between patients who would benefit from surgery intervention. The most promising results were obtained using NGAL, RBP, TGF-ß1, and KIM-1, especially in the unilateral hydro(uretero)nephrosis and LUTO subgroups when compared with the control group. CONCLUSIONS: Urine biomarkers, alone and in combination, demonstrated high potential as a non-invasive diagnostic tool for identifying infants who may benefit from earlier surgical intervention.
Assuntos
Tomada de Decisão Clínica , Obstrução Ureteral/metabolismo , Obstrução Ureteral/cirurgia , Obstrução Uretral/metabolismo , Obstrução Uretral/cirurgia , Obstrução do Colo da Bexiga Urinária/metabolismo , Obstrução do Colo da Bexiga Urinária/cirurgia , Biomarcadores/sangue , Feminino , Humanos , Lactente , Masculino , Valor Preditivo dos Testes , Obstrução Ureteral/congênito , Obstrução Uretral/congênito , Obstrução do Colo da Bexiga Urinária/congênito , Procedimentos Cirúrgicos UrológicosRESUMO
BACKGROUND: Chronic allograft vasculopathy (CAV) is an important cause of graft loss. Considering the immune inflammatory events involved in the development of CAV, therapeutic approaches to target this process are of relevance. Human amniotic fluid-derived stem cells (hAFSCs), a class of fetal, pluripotent stem cells with intermediate characteristics between embryonic and adult stem cells, display immunomodulatory properties. hAFSCs express mesenchymal and embryonic markers, show high proliferation rates; however, they do not induce tumor formation, and their use does not raise ethical issues. Thus, we sought to investigate the effect of hAFSC on CAV in a model of aorta transplantation. METHODS: Orthotopic aorta transplantation was performed using Fisher (F344) rats as donors and Lewis rats as recipients. Rats were divided into three groups: syngeneic (SYNG), untreated F344 receiving aorta from F344 (n = 8); allogeneic (ALLO), Lewis rats receiving allogeneic aorta from F344 (n = 8); and ALLO + hAFSC, ALLO rats treated with hAFSC (10(6) cells; n = 8). Histological analysis and immunohistochemistry were performed 30 days posttransplantation. RESULTS: The ALLO group developed a robust aortic neointimal formation (208.7 ± 25.4 µm) accompanied by a significant high number of ED1+ (4845 ± 841 cells/mm2) and CD43+ cells (4064 ± 563 cells/mm2), and enhanced expression of α-smooth muscle actin in the neointima (25 ± 6%). Treatment with hAFSC diminished neointimal thickness (180.7 ± 23.7 µm) and induced a significant decrease of ED1+ (1100 ± 276 cells/mm2), CD43+ cells (1080 ± 309 cells/µm2), and α-smooth muscle actin expression 8 ± 3% in the neointima. CONCLUSIONS: These preliminary results showed that hAFSC suppressed inflammation and myofibroblast migration to the intima, which may contribute to ameliorate vascular changes in CAV.
Assuntos
Líquido Amniótico/citologia , Aorta Abdominal/transplante , Doenças da Aorta/prevenção & controle , Células-Tronco Fetais/transplante , Transplante de Órgãos/efeitos adversos , Células-Tronco Pluripotentes/transplante , Actinas/metabolismo , Animais , Aorta Abdominal/imunologia , Aorta Abdominal/metabolismo , Aorta Abdominal/patologia , Doenças da Aorta/etiologia , Doenças da Aorta/imunologia , Doenças da Aorta/metabolismo , Doenças da Aorta/patologia , Biomarcadores/metabolismo , Movimento Celular , Células Cultivadas , Células-Tronco Fetais/imunologia , Células-Tronco Fetais/metabolismo , Humanos , Imuno-Histoquímica , Masculino , Miofibroblastos/metabolismo , Miofibroblastos/patologia , Neointima , Células-Tronco Pluripotentes/imunologia , Células-Tronco Pluripotentes/metabolismo , Ratos , Ratos Endogâmicos F344 , Ratos Endogâmicos Lew , Fatores de TempoRESUMO
OBJETIVO: Estudar a avaliaçäo da maturidade fetal em gestaçöes de alto risco e analisar os resultados neonatais. MÉTODOS: Entre julho de 1998 e agosto de 1999 foram realizadas, no Setor de Vitalidade Fetal da Clínica Obstétrica do HC-FMUSP, 180 amniocenteses para avaliaçäo da maturidade fetal, sendo realizados os testes de Clements em três tubos e a contagem de células orangiófilas coradas com Azul de Nilo a 0,1 por cento. Os resultados perinatais foram correlacionados com a maturidade fetal em 75 casos cujo parto ocorreu até sete dias após a punçäo. RESULTADOS: Na macroscopia, 91 por cento das amostras apresentavam líquido amniótico claro, 3,3 por cento meconial e 5,6 por cento hemorrágico. A maturidade foi observada em 28 por cento dos exames realizados. Na avaliaçäo dos resultados perinatais, quando a maturidade estava ausente, a necessidade de intubaçäo do recém-nascido ocorreu em três casos (13 por cento) e nos fetos maduros isto ocorreu em um caso (2,5 por cento) (p<0,05). A necessidade de internaçäo em UTI neonatal ocorreu em 65 por cento dos recém-nascidos que apresentavam líquido imaturo e em apenas 10 por cento dos maduros (p<0,0001). CONCLUSÖES: Os recém-nascidos das gestantes com maturidade fetal presente apresentaram com menor freqüência necessidade de intubaçäo na sala de parto e de internaçäo em UTI neonatal, demonstrando menor morbidade perinatal. Entre a 29ª e a 32ª semana de gestaçäo, foram observados cerca de 10 por cento de fetos maduros, demonstrando que, quando necessário, a avaliaçäo da maturidade pode ser realizada neste período da gravidez. Näo observamos casos com maturidade fetal abaixo de 29 semanas, limitando a realizaçäo deste exame neste período